Showing results (5321-5330 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 29, 2002
Quantitative structure-activity relationship studies on cholecystokinin antagonistsSatya P GuptaCurrent Pharmaceutical Design|January 29, 2002
The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s diseaseL E Schechter, L A Dawson, J A HarderCurrent Pharmaceutical Design|January 29, 2002
Progress in the development of selective nitric oxide synthase (NOS) inhibitorsL Salerno, V Sorrenti, C Di Giacomo, et al.Current Pharmaceutical Design|January 29, 2002
The nitric oxide related therapeutic phenomenon: a challenging taskM J Alcaraz, M I GuillnCurrent Pharmaceutical Design|July 23, 2002
Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor designDieter Brömme, Jadwiga KaletaCurrent Pharmaceutical Design|October 9, 2002
BAY 43-9006: early clinical data in patients with advanced solid malignanciesSebastien J Hotte, Hal W HirteCurrent Pharmaceutical Design|October 9, 2002
BAY 43-9006: preclinical dataScott Wilhelm, Du-Shieng ChienCurrent Pharmaceutical Design|October 9, 2002
Therapeutic enhancement of IL-2 through molecular designDelanie J Cassell, Shurjeel Choudhri, Rachel Humphrey, et al.Current Pharmaceutical Design|October 9, 2002
Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF)Cristina Monfardini, Gabriela Canziani, Carmela Plugariu, et al.Current Pharmaceutical Design|October 9, 2002
Rational design and development of RDP58Suhasini Iyer, Roger Lahana, Roland BuelowPageof 1,008